Dr Amanda Xiaoqing Mao, PhD As an experienced professional in international business development and clinical project management, Dr Mao’s skills encompass the entire clinical trial journey. Specifically, Dr Mao is a bridge between Australia & China in clinical research. Having an extensive professional network in China, Dr Mao helps Australian CROs develop strong relationships with as well as carry out clinical trials for Chinese biotech companies/sponsors. Dr Mao has a wealth of experience in planning and managing end-to-end international clinical projects from commencement to completion, ensuring they are delivered on time and on budget. With over 15 years of career history in the pharmaceutical and nutrition industries across China and Australia, Dr Mao’s experience covers broad therapeutic areas such as oncology, rare disease, immunology, paediatrics, gastroenterology, metabolic disorders, and neurology. Dr Mao is Founder, Director, and Principal Consultant at Acurit Medical Communications. Her other experiences include Alliance and Project Management Lead at Keros Therapeutics, USA; Scientific Project Director – China at Edanz Inc., Japan; and Senior Medical Affairs Manager, Asia Pacific at Pfizer, China. Dr Mao is a member of the Health and Medical Research Working Group at Australia China Business Council (ACBC), Victoria branch. She has been invited multiple times to present about cross-border clinical trials between Australia and China. Dr Mao received her PhD in Biochemistry at the University of Missouri – Columbia in the US, and her Bachelor's and Master’s in life sciences in China.